Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Artificial intelligence in clinical allergy practice: current status, challenges, and future directions

View through CrossRef
Artificial intelligence (AI) is poised to transform clinical allergy practice by enhancing diagnostic accuracy, personalising treatment, and streamlining healthcare delivery. This narrative review critically examines the current landscape of AI in allergy care, spanning clinical workflows, diagnostics, immunotherapy, and research applications. AI-powered tools such as clinical decision support systems (CDSS), natural language processing (NLP), and conversational agents are being integrated into allergy services, offering improvements in documentation, risk stratification, and remote patient engagement—particularly in paediatric and multilingual settings. Diagnostic innovations include machine learning models that predict oral food challenge outcomes and interpret multi-omics data for personalised allergy phenotyping. AI also supports adaptive immunotherapy dosing, remote monitoring via wearable biosensors, and digital coaching to promote adherence. Federated learning and explainable AI (XAI) emerge as pivotal developments—enabling privacy-preserving collaboration and fostering trust among clinicians and patients. Despite these advancements, significant challenges remain. These include data inequities, algorithmic bias, lack of real-world validation, and regulatory ambiguity. The “black box” nature of many models risks undermining clinician confidence, while over-reliance on alerts could contribute to alarm fatigue. Ethical concerns—particularly around transparency, consent, and liability—require urgent attention. Equitable implementation demands robust governance, diverse training data, and inclusive design that prioritises patient safety. Looking ahead, AI has the potential to power digital twins, support augmented reality training, and enhance allergy surveillance through the integration of environmental and population-level data. With multidisciplinary collaboration, transparent oversight, and patient-centred innovation, AI can help build a more predictive, efficient, and equitable future for allergy care.
Title: Artificial intelligence in clinical allergy practice: current status, challenges, and future directions
Description:
Artificial intelligence (AI) is poised to transform clinical allergy practice by enhancing diagnostic accuracy, personalising treatment, and streamlining healthcare delivery.
This narrative review critically examines the current landscape of AI in allergy care, spanning clinical workflows, diagnostics, immunotherapy, and research applications.
AI-powered tools such as clinical decision support systems (CDSS), natural language processing (NLP), and conversational agents are being integrated into allergy services, offering improvements in documentation, risk stratification, and remote patient engagement—particularly in paediatric and multilingual settings.
Diagnostic innovations include machine learning models that predict oral food challenge outcomes and interpret multi-omics data for personalised allergy phenotyping.
AI also supports adaptive immunotherapy dosing, remote monitoring via wearable biosensors, and digital coaching to promote adherence.
Federated learning and explainable AI (XAI) emerge as pivotal developments—enabling privacy-preserving collaboration and fostering trust among clinicians and patients.
Despite these advancements, significant challenges remain.
These include data inequities, algorithmic bias, lack of real-world validation, and regulatory ambiguity.
The “black box” nature of many models risks undermining clinician confidence, while over-reliance on alerts could contribute to alarm fatigue.
Ethical concerns—particularly around transparency, consent, and liability—require urgent attention.
Equitable implementation demands robust governance, diverse training data, and inclusive design that prioritises patient safety.
Looking ahead, AI has the potential to power digital twins, support augmented reality training, and enhance allergy surveillance through the integration of environmental and population-level data.
With multidisciplinary collaboration, transparent oversight, and patient-centred innovation, AI can help build a more predictive, efficient, and equitable future for allergy care.

Related Results

Identification of predictors for persistence of immediate-type egg allergy in Chinese children
Identification of predictors for persistence of immediate-type egg allergy in Chinese children
Background Egg allergy is one of the most common food allergies in childhood with increasing prevalence in Hong Kong. While ample studies were published on its optimal ...
Oral Allergy Syndrome
Oral Allergy Syndrome
Objectives To review oral allergy syndrome (OAS). Methods We searched several medical literature data bases with the following key words: “oral allergy syndrome,” “OAS,” “pollen-fo...
Diagnosis of allergy syndromes: do symptoms always mean allergy?
Diagnosis of allergy syndromes: do symptoms always mean allergy?
Allergic disease has become a major burden in westernized societies because of a recent rise in its prevalence. Approximately one‐third of children suffer from an allergic disease,...
Early-life Gut Microbiota in Food Allergic Children and Its Impact on The Development of Allergic Disease
Early-life Gut Microbiota in Food Allergic Children and Its Impact on The Development of Allergic Disease
Abstract Background: The prevalence of food allergy (FA) has been increasing steadily over the past 2 decades to 3 decades, with diversified symptoms and increasing severit...
Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia
Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia
Abstract Background Penicillin allergy frequently impacts antibiotic choice. As beta-lactams are superior to vancomycin in treat...
Pediatric allergy and immunology in Italy
Pediatric allergy and immunology in Italy
To cite this article: Tozzi AE, Armenio L, Bernardini R, Boner A, Calvani M, Cardinale F, Cavagni G, Dondi A, Duse M, Fiocchi A, Marseglia GL, Miraglia del Giudice M, Muraro A, Paj...

Back to Top